Top Markets
Coin of the day
AnnJi AnnJi

AnnJi

7754
Clasificación en acciones #18684
Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co.,... Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co., Ltd. specializes in the creation of innovative medicinal treatments. The company's research and development pipeline addresses neurological, dermatological, and inflammatory conditions. Among its key therapeutic candidates are AJ201, which is being developed for the neurodegenerative disorder spinal and bulbar muscular atrophy, and AJ202, targeting androgenetic alopecia. AnnJi also works on AJ302, a histone deacetylase 6 inhibitor aimed at preventing and treating chemotherapy-induced peripheral neuropathy, and AJ303, an anti-fibrotic and anti-inflammatory agent intended for idiopathic pulmonary fibrosis and other fibrotic diseases.
Precio por acción
$1.88
Capitalización bursátil
$190.02M
Cambio (1 día)
0.51%
Cambio (1 año)
24.67%
País
TW
Comercio AnnJi (7754)

Categoría

Ganancias de AnnJi (7754)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di AnnJi, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de AnnJi desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$5.27B -
US
$1.95B -
NL
$-3.09B -
US
$-4.02B -
AU
- -
CH